-+ 0.00%
-+ 0.00%
-+ 0.00%

AGENUS ANNOUNCES THREE-YEAR SURVIVAL DATA FROM PHASE 1B BOT+BAL STUDY IN MSS METASTATIC COLORECTAL CANCER TO BE PRESENTED AT ESMO GI 2026

Reuters·06/25/2026 11:00:00

Please log in to view news